![Elizabeth Masson-Hurlburt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Elizabeth Masson-Hurlburt
Directeur des opérations chez
CORMEDIX INC.
Fortune : 2 M $ au 30/06/2026
Profil
Elizabeth Masson-Hurlburt is currently Chief Operating & Commercial Officer at CorMedix, Inc., a position starting in 2026.
Formerly, Ms. Masson-Hurlburt was Vice President-Clinical Operations at Gemphire Therapeutics, Inc. from 2016 to 2018.
Education includes an undergraduate degree from Bay Path College and a graduate degree from Western Governors University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CORMEDIX INC. 0,36% | 04/02/2026 | 278 539 ( 0,36% ) | 2 M $ | 30/06/2026 |
Postes actifs de Elizabeth Masson-Hurlburt
| Sociétés | Poste | Début |
|---|---|---|
| CORMEDIX INC. | Directeur des opérations | - |
Anciens postes connus de Elizabeth Masson-Hurlburt
| Sociétés | Poste | Fin |
|---|---|---|
| METAVIA INC. | Directeur Technique/Scientifique/R&D | 01/03/2018 |
Formation de Elizabeth Masson-Hurlburt
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
33
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
CorMedix, Inc.
 CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Bay Path College
 Bay Path College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Governors University
 Western Governors University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
